The aims of our study were to use meta-analysis to demonstrate the correlation between FOXP3+ TILs and the clinicopathological characteristics of breast cancer and evaluate whether detection of FOXP3+ TILs can act as a clinical predictor for patients with breast cancer. Here, FOXP3 is linked to breast cancer.